What are the Challenges in Targeting Phagocytosis in Cancer?
While targeting phagocytosis holds promise, several challenges remain. One major issue is the specificity of treatments; enhancing phagocytosis indiscriminately could lead to autoimmune reactions where healthy cells are also targeted. Additionally, the tumor microenvironment can be immunosuppressive, further complicating the efficacy of such therapies.
